𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions

✍ Scribed by Sam J.P. Gobin; Lisette Montagne; Marlijn Van Zutphen; Paul Van Der Valk; Peter J. Van Den Elsen; Corline J.A. De Groot


Book ID
102846990
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
1001 KB
Volume
36
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The expression of major histocompatibility complex (MHC) class I and class II in the CNS has received considerable interest because of its importance in neurodegenerative or inflammatory diseases, such as multiple sclerosis (MS). However, at the moment nothing is known about the expression patterns of transcription factors controlling MHC expression in MS lesions. Here, we performed an extensive immunohistochemical analysis on MS affected postmortem brain tissue to determine the cellular localization and distribution of different MHC‐controlling transcription factors. We show that phagocytic macrophages in active demyelinating MS lesions displayed a moderate to strong immunostaining of the MHC‐specific transcription factors RFX and CIITA, as well as the general transcription factors NF‐κB, IRF1, STAT1, USF, and CREB, which was congruent with a strongly enhanced expression of HLA‐DR, HLA‐DQ, HLA‐DP, and HLA class I. In the normal‐appearing white matter (NAWM), clusters of activated microglial cells forming preactive lesions displayed an overall stronger expression level of these transcription factors, combined with a strong to intense level of MHC class I and class II immunostaining. In general, astrocytes and oligodendrocytes either did not express, or weakly expressed, these transcription factors, correlating with a lack of MHC class II and weak MHC class I expression. Together, the elevated expression level of transcription factors governing expression of MHC class I and class II molecules in activated microglial cells and phagocytic macrophages strongly suggests a general state of microglial cell activation in MS lesions. GLIA 36:68–77, 2001. © 2001 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES